| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.06 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.07 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.08 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.08 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.08 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |